Cited by 107Probiotics and Fermented FoodsAntifungal resistance and susceptibilityComplementary and Alternative Medicine Studies

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; none of the 2 sources its claims cite is checked for support yet.

Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series

Open access
Costa, Rafael Lessa, Moreira, José, Lorenzo, Andrea, Lamas, Cristiane C.·2018·BMC Complementary and Alternative Medicine

Abstract

BACKGROUND: Little is studied about complications related to probiotic ingestion. This study proposes to present a synthesis and critical evaluation of the reports and series of cases on the infectious complications related to the ingestion of probiotics, which can raise awareness for the prescribing and use of probiotics for certain groups of patients. METHODS: Systematic review of reports and series of cases researched in the PubMed, SciELO and Scopus databases published until August 2018. The references of the articles were investigated manually for the search of cross references. SPSS version 23.0 was used for descriptive statistics and univariate analysis. RESULTS: We found 60 case reports and 7 case series, making up a total of 93 patients. Fungemia was the most common infectious complications with 35 (37.6%) cases. The genus Saccharomyces was the most frequent with 47 (50.6%) cases, followed by Lactobacillus, Bifidobacterium, Bacillus, Pedioccocus and Escherichia with 26 (27.9%), 12 (12.8%), 5 (5.4%), 2 (2.2%) and 1 (1.1%) case, respectively. Adults over 60 years of age, Clostridium difficile colitis, antibiotic use and Saccharomyces infections were associated with overall mortality. HIV infections, immunosuppressive drugs, solid organ transplantation, deep intravenous lines, enteral or parenteral nutrition were not associated with death. CONCLUSION: The use of probiotics cannot be considered risk-free and should be carefully evaluated for some patient groups. TRIAL REGISTRATION: CRD42016042289.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This systematic review of 60 case reports and 7 case series (93 patients, 1976–2018) found infectious complications after probiotic ingestion, most commonly fungemia and Saccharomyces infection. Mortality was associated with age >60 years, C. difficile colitis, antibiotic use, and Saccharomyces infection.

Key findings

  • Among 93 patients, fungemia was most common at 35 (37.6%), followed by sepsis 29 (31.2%), bacteremia 19 (20.4%), endocarditis 4, and abscess 3; pneumonia, pleural empyema, and septic arthritis each occurred in 1 case.
  • Saccharomyces was the most frequent genus with 47 (50.6%) cases, including S. cerevisiae 41 (44.1%), S. boulardii 5 (5.4%), and Saccharomyces spp. 1 (1.1%); Lactobacillus accounted for 26 (27.9%), Bifidobacterium 12 (12.8%), Bacillus 5 (5.4%), Pediococcus 2 (2.2%), and Escherichia coli 1 (1.1%).
  • All-cause mortality was 19.6% (18 cases) and was associated with age >60 years (OR 6.25, 95% CI 1.89–20.1; p=0.003), C. difficile colitis (OR 11.8, 95% CI 2.89–48.81; p<0.001), antibiotic use (OR 9.75, 95% CI 1.51–17.11; p=0.002), and Saccharomyces spp. (OR 4.9, 95% CI 1.30–15.48; p=0.03). HIV infection, immunosuppressive drugs, solid organ transplantation, deep intravenous lines, and enteral or parenteral nutrition were not associated with death.
  • Blood was the most frequent isolation site, in 87 (93.5%) cases.

Methods

  • Systematic review of case reports and case series searched in PubMed, SciELO, and Scopus from inception to August 8, 2018, with manual reference cross-checking; no language restriction; reported per PRISMA and registered at PROSPERO (CRD42016042289).
  • Included infections after probiotic ingestion, including bacteremia/fungemia, sepsis, endocarditis, and abscess; 6797 records plus 55 cross-references yielded 67 articles (60 case reports, 7 case series) corresponding to 93 patients.
  • Descriptive statistics and univariate analysis used SPSS version 23.0; categorical variables compared with chi-square and Fisher’s exact tests, continuous variables with Mann-Whitney test, two-tailed p<0.05; risk of bias assessed with a modified National Institutes of Health tool.

Limitations

  • The paper states possible publication bias, with more serious cases more likely published, but also notes that case reports are increasingly difficult to publish, so other serious cases may not have reached public knowledge.
  • The paper states that the mortality analysis did not consider other factors such as numbers and types of comorbidity, and that the review is not intended to discourage probiotic use.
  • Evident from the text: case reports and case series cannot establish causality or incidence, and there is no denominator of all probiotic users; risk of bias was mostly “fair” (7/67, 10.4%, were “good”; none “poor”).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12906-018-2394-3

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Flow diagram of the article selection process at each stage of the systematic review
Fig. 1 Flow diagram of the article selection process at each stage of the systematic reviewCC BY · PubMed Central

Verification

Claims the paper makes

60 Own result · 6 Own interpretation · 4 Own method · 2 Not checked yet · 1 No basis given

Verify all 2 references — free account
  • It may state two separate claims as one. 18
  • Probably not a substantial claim. 23
37 of 37
  • The paper relies on this without support.

    Compatibility between a microorganism isolated from a patient and the probiotic product taken indicates that the probiotic caused the infection.

    “In 27 cases, the probiotic microorganisms in the medications were compatible with the isolates found in the blood samples of the patient.”
    “In 15 cases, additional methods showed that the microorganisms isolated from biological samples were compatible with the probiotics taken by the patients.”
  • The paper relies on this without support.

    Case reports are increasingly difficult to publish.

    “We believe that these cases represent only a small proportion of existing cases, since case reports are increasingly difficult to publish.”
  • The paper relies on this without support.

    The total number of people who use probiotics is large enough that the proportion of infectious complications is small.

    “The proportion of cases of infectious complications is small when the total number of people who use probiotics is considered.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 31 references

Research works printed but not linked: 1

  1. FAO/WHO. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report, 2001.

Cited by

Sorted by citations

See all 107

Metadata

Authors
Costa, R. L., Moreira, J., Lorenzo, A., & Lamas, C. C.
Affiliations
Instituto Nacional de Cardiologia (BR)
Corresponding author
Costa, Rafael Lessa
Venue
BMC Complementary and Alternative Medicine
Published
2018-12
Volume
18
Issue
1
Pages
329-329
ISSN
1472-6882 (ISSN-L)
OpenAlex
W2905075966
Cited by
105
References
31
Citations by year
2026: 20 · 2025: 15 · 2024: 12 · 2023: 6 · 2022: 10 · 2021: 20 · 2020: 15 · 2019: 7
FWCI
1.06
Type
journal article
Language
en
Open access
Locations
  • BMC Complementary and Alternative Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Arca - Repositório Institucional da Fiocruz (publishedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Funders
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (202.782/2015)
  • National Institutes of Health
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
Keywords
probiotics, infectious complications, fungemia, Saccharomyces, Lactobacillus, Bifidobacterium, Bacillus, Clostridium difficile colitis, mortality, antibiotic use, immunosuppression, elderly patients, probiotic safety
MeSH terms
Administration, Oral, Adolescent, Adult, Aged, Aged, 80 and over, Bifidobacterium, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Lactobacillus, Male, Middle Aged, Mycoses, Saccharomyces, Gram-Positive Bacterial Infections, Probiotics, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review